Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)
This study is recruiting. It focuses on depression and currently lists participation information in the United States.
In New York
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on depression and currently lists participation information in the United States.
In New YorkThis study is recruiting. It focuses on PTSD and currently lists participation information in Japan.
Multiple locations, including YamanashiThis study is recruiting. It focuses on mental health and currently lists participation information in Singapore.
In SingaporeThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In New HavenThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on anxiety and currently lists participation information in Australia.
In ParkvilleThis study is recruiting. It focuses on depression and currently lists participation information in China.
In Kowloon TongThis study is recruiting. It focuses on mental health and currently lists participation information in France.
In BronThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In San DiegoThis study is recruiting. It focuses on ADHD and currently lists participation information in the United States.
In AuroraThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In IndianapolisThis study is recruiting. It focuses on ADHD and currently lists participation information in Hungary.
In BudapestHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.